本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AbCellera Biologics

2.56
+0.04001.59%
成交量:325.51万
成交额:840.27万
市值:7.63亿
市盈率:-4.63
高:2.68
开:2.59
低:2.51
收:2.52
数据加载中...
2022/07/22

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/07/19

重要事件披露

8-K - Current report
2022/07/06

重要事件披露

8-K - Current report
2022/06/30

重要事件披露

8-K - Current report
2022/06/21

重要事件披露

8-K - Current report
2022/05/10

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/15

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/07

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities